(SMMT) Summit Therapeutics - Performance 790.9% in 12m
Compare SMMT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
57.08%
#8 in Group
Rel. Strength
99.93%
#7 in Universe
Total Return 12m
790.88%
#3 in Group
Total Return 5y
820.50%
#1 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -0.98%
50th Percentile in Group
12m Total Return: SMMT (790.9%) vs XBI (-6.5%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
| LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
| GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: SMMT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SMMT
| Total Return (including Dividends) | SMMT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 60.61% | -10.94% | -6.73% |
| 3 Months | 34.81% | -14.92% | -11.93% |
| 12 Months | 790.88% | -6.46% | 7.24% |
| 5 Years | 820.50% | -19.21% | 100.61% |
| Trend Score (consistency of price movement) | SMMT | XBI | S&P 500 |
| 1 Month | 60.3% | -52.8% | -63.5% |
| 3 Months | -8.40% | -92.8% | -90.3% |
| 12 Months | 73.1% | -32.4% | 60.6% |
| 5 Years | 20.1% | -53.3% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #4 | 80.4% | 72.2% |
| 3 Month | #9 | 58.5% | 53.1% |
| 12 Month | #3 | 852% | 731% |
| 5 Years | #2 | 1,039% | 359% |
FAQs
Does SMMT Summit Therapeutics outperforms the market?
Yes,
over the last 12 months SMMT made 790.88%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months SMMT made 34.81%, while XBI made -14.92%.
Over the last 3 months SMMT made 34.81%, while XBI made -14.92%.
Performance Comparison SMMT vs Indeces and Sectors
SMMT vs. Indices SMMT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 42.3% | 67.3% | 72.7% | 784% |
| US NASDAQ 100 | QQQ | 41.8% | 68.0% | 72.5% | 783% |
| US Dow Jones Industrial 30 | DIA | 44.3% | 67.5% | 72.1% | 786% |
| German DAX 40 | DAX | 41.1% | 64.6% | 52.8% | 771% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 42.9% | 64.0% | 71.5% | 782% |
| Hongkong Hang Seng | HSI | 39.6% | 64.3% | 68.1% | 774% |
| India NIFTY 50 | INDA | 40.2% | 58.6% | 69.3% | 788% |
| Brasil Bovespa | EWZ | 38.0% | 60.2% | 67.6% | 800% |
SMMT vs. Sectors SMMT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 41.6% | 67.5% | 63.5% | 776% |
| Consumer Discretionary | XLY | 40.9% | 67.5% | 67.4% | 780% |
| Consumer Staples | XLP | 42.2% | 57.6% | 64.7% | 780% |
| Energy | XLE | 42.2% | 73.1% | 74.0% | 804% |
| Financial | XLF | 41.6% | 65.5% | 63.8% | 773% |
| Health Care | XLV | 44.6% | 68.4% | 74.9% | 793% |
| Industrial | XLI | 42.9% | 66.6% | 72.8% | 787% |
| Materials | XLB | 42.6% | 66.5% | 79.9% | 797% |
| Real Estate | XLRE | 42.5% | 63.8% | 73.0% | 776% |
| Technology | XLK | 42.0% | 69.6% | 78.9% | 790% |
| Utilities | XLU | 42.4% | 60.4% | 69.0% | 769% |
| Aerospace & Defense | XAR | 43.8% | 63.8% | 63.3% | 769% |
| Biotech | XBI | 38.9% | 71.6% | 84.1% | 797% |
| Homebuilder | XHB | 40.8% | 68.7% | 87.4% | 801% |
| Retail | XRT | 40.4% | 66.0% | 76.1% | 797% |